OpenAI has secured major health system customers, including Cedars-Sinai and HCA Healthcare, and is expanding health-focused products for clinicians and consumers, such as a clinician version of ChatGPT and ChatGPT Health for personal medical data.

Health-focused AI is driving operational gains, with Advent Health reporting substantial time savings in administrative tasks through OpenAI models, alongside partnerships with diagnostics firms like Labcorp to build AI tools for viewing and tracking lab results.

OpenAI has mobilized a large physician network—over 260 doctors—to train and validate health models and reduce errors in medical guidance.

The company faces competition from Anthropic, Google, and other health tech players, while balancing pricing with hospital margins as it expands its healthcare enterprise footprint.

Health is a strategic vertical for OpenAI due to its economic scale, with a stance that AI should augment clinical care, backed by ongoing clinician feedback and testing to improve model reliability.

Sam Altman is actively pitching health systems on OpenAI’s healthcare ambitions, underscoring healthcare’s strategic importance to the business.

Clinical and user experiences show both benefits and risks of AI in health, including improved guidance in some cases and concerns about misinformation or unnecessary care, highlighting the need for oversight and physician involvement.

The initiative aims to enhance healthcare delivery and administrative efficiency, positioning OpenAI as a key player in the sector.

Partnerships with Labcorp and collaborations with startups are expanding clinical tool use, signaling potential future IPO considerations.

OpenAI has rolled out three new healthcare AI products in six months for hospitals, doctors, and patients to improve care and efficiency.

The company is working with major health systems and hundreds of physicians to improve the accuracy of ChatGPT’s health guidance for a broad audience seeking medical information.